We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The National Institutes of Health (NIH) has paused enrollment of critically ill COVID-19 patients in a phase 3 trial of various blood thinners, one of three international trials evaluating whether a full or lower dose of anticoagulants in hospitalized COVID-19 patients is more effective. Read More
Malvern, Pa.-based biotech Ocugen and India’s Bharat Biotech have agreed to work together to develop the Indian company’s COVID-19 vaccine for use in the U.S., a product that is already far along in clinical trials. Read More
Vaccine makers are currently evaluating if a new, highly contagious COVID-19 strain identified in the UK could slip past their shots, but Pfizer/BioNTech, Moderna and others are confident their vaccines will protect against the new mutation, which is likely already in the U.S. Read More
In observance of the holiday season, Drug Industry Daily will not be published Thursday, Dec. 24 or Friday, Dec. 25. The next issue will be published Monday, Dec. 28. Read More
French drugmaker Servier is expanding its reach into cancer drugs by acquiring Agios Pharmaceutical’s oncology business in a deal valued at up to $2 billion. Read More
The FDA has placed a clinical hold on uniQure’s entire clinical development program for its investigational gene therapy for hemophilia B after a patient participating in a pivotal phase 3 clinical trial was given a preliminary diagnosis of liver cancer, the company announced Monday. The serious adverse event was included in a mid-December safety report on the trial as being possibly related to the patient’s treatment with the investigational gene therapy, etranacogene dezaparvovec (AMT-061) in October 2019. Read More
CanSino Biologics has enrolled more than 20,000 participants in a global phase 3 study of its COVID-19 vaccine candidate, Ad5-nCoV, co-developed with a research arm of the Chinese military. Read More
The House Select Subcommittee on the Coronavirus Crisis issued subpoenas on Monday to the chiefs of HHS and the Centers for Disease Control and Prevention (CDC), demanding documents relating to the Democrats’ investigation of alleged political tampering with coronavirus response efforts. Read More
Ending months of haggling between lawmakers, Congress passed an omnibus appropriations bill and COVID-19 relief package late Monday with a seven-day continuing resolution in place to keep the government funded at fiscal 2020 levels until the legislation is signed into law as expected. Read More